Page last updated: 2024-08-21

3',5'-dichloromethotrexate and Carcinoma, Non-Small Cell Lung

3',5'-dichloromethotrexate has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlgren, JD; Gullo, JJ; Lokich, JJ; Phillips, JA; Wampler, GL	1

Trials

1 trial(s) available for 3',5'-dichloromethotrexate and Carcinoma, Non-Small Cell Lung

Article	Year
Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP study. American journal of clinical oncology, 1991, Volume: 14, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate	1991

Article

Year

Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP study.

American journal of clinical oncology, 1991, Volume: 14, Issue:5

Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate

1991